Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes

JAMA Intern Med. 2020 Jul 1;180(7):1012-1014. doi: 10.1001/jamainternmed.2020.1308.

Abstract

This study evaluates inpatient, outpatient, and pharmacy claims to identify the annual out-of-pocket expenditures for both insured children and adults with type 1 diabetes.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Drug Costs*
  • Female
  • Health Expenditures / trends*
  • Health Services / economics*
  • Humans
  • Hypoglycemic Agents / economics
  • Hypoglycemic Agents / supply & distribution
  • Infant
  • Insulin / economics*
  • Insulin / supply & distribution
  • Insurance, Health / economics*
  • Male
  • Middle Aged
  • United States
  • Young Adult

Substances

  • Hypoglycemic Agents
  • Insulin